Saul Flores

Dr. Saul Flores

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2020 in Annals of Medicine
Verified
Journal Article
Open access
Rohit LoombaRohit Loomba
Rohit Loomba
GAGaurav Aggarwal
Gaurav Aggarwal
SASaurabh Aggarwal
Saurabh Aggarwal
SFSaul Flores
Saul Flores
EVEnrique G. Villarreal
Enrique G. Villarreal
CLCarl J Lavie
Carl J Lavie
To utilize publicly reported, state-level data to identify factors associated with the frequency of cases, tests, and mortality in the USA. Retrospective study using publicly reported data collected included the number of COVID-19 cases, tests and mortality from March 14th through April 30th. Publicly available state-level data was collected which included: demographics comorbidities, state characteristics and environmental factors. Univariate and multivariate regression analyses were performed to identify the significantly associated factors with percent mortality, case and testing frequency. All analyses were state-level analyses and not patient-level analyses. A total of 1,090,500 COVID-19 cases were reported during the study period. The calculated case and testing frequency were 3332 and 19,193 per 1,000,000 patients. There were 63,642 deaths during this period which resulted in a mortality of 5.8%. Factors including to but not limited to population density (beta coefficient 7.5, p < .01), transportation volume (beta coefficient 0.1, p < .01), tourism index (beta coefficient -0.1, p = .02) and older age (beta coefficient 0.2, p = .01) are associated with case frequency and percent mortality. There were wide variations in testing and case frequencies of COVID-19 among different states in the US. States with higher population density had a higher case and testing rate. States with larger population of elderly and higher tourism had a higher mortality. Key messages There were wide variations in testing and case frequencies of COVID-19 among different states in the USA. States with higher population density had a higher case and testing rate. States with larger population of elderly and higher tourism had a higher mortality.

12 September 2021 in Journal of Clinical Pharmacy and Therapeutics
Verified
Journal Article
Open access
PDF file
Rohit LoombaRohit Loomba
Rohit Loomba
EVEnrique G. Villarreal
Enrique G. Villarreal
JDJanhavi Dhargalkar
Janhavi Dhargalkar
JRJacqueline Rausa
Jacqueline Rausa
VDVincent Dorsey
Vincent Dorsey
SFSaul Flores
Saul Flores
What is known and objective Acute kidney injury (AKI) is a complication following surgery and has been associated with worsened patient outcomes. Providers have used agents that may confer a degree of renal protection in the perioperative stage. Such is the case of dexmedetomidine, a selective alpha-2 adrenergic agonist used in the intensive care unit (ICU) as a sedative agent. The primary objective of this meta-analysis was to characterize the use of dexmedetomidine and to evaluate its impact on renal markers and outcomes in patients after surgery. Methods A systematic review of manuscripts was performed to identify patients who received dexmedetomidine after surgery by searching the PubMed, Embase, and Cochrane databases. The following parameters were captured: blood urea nitrogen (BUN), serum creatinine, creatinine clearance, neutrophil gelatinase-associated lipoprotein (NGAL), cystatin C, urine output, duration of mechanical ventilation, ICU length of stay, AKI, need for dialysis, and mortality. Results and Discussion Nineteen studies with 3,395 patients were included in the analyses. The mean bolus and infusion dose of dexmedetomidine were 0.82 µg/kg and 0.54 mcg/kg/hr, respectively. There was a significant difference in creatinine clearance and NGAL in favour of the dexmedetomidine group. In addition, the dexmedetomidine group had a shorter ICU length of stay, and a lower risk of acute kidney injury and mortality compared to the control. There was no difference in the rest of the parameters. What is new and conclusion Dexmedetomidine appears to have postoperative renal protective effects. This is evidenced by lower NGAL levels and increased creatinine clearance in those who received dexmedetomidine. These effects are associated with decreases in ICU length of stay and risk of AKI and mortality.

27 August 2019 in Congenital Heart Disease
Verified
Journal Article
Closed access
PDF file
Rohit LoombaRohit Loomba
Rohit Loomba
SFSaul Flores
Saul Flores
Objective The main goal of this study is to examine the variation in vasoactive agent prescription patterns across a large cohort of patients. In addition, we sought to determine the association between the number of vasoactive agents used during admissions and characteristics of admissions utilizing varying numbers of vasoactive agents. Methods This was a multi‐institutional, cross‐sectional study of the pediatric health information system database of patients who underwent congenital heart surgery and received vasoactive agents from 2004 to 2015. The international classification of disease‐9 (ICD‐9) codes were used to select admissions to those only pertaining to cardiac patients. The vasoactive agents investigated included epinephrine, norepinephrine, dopamine, dobutamine, milrinone, and vasopressin. Results A total of 43 441 postoperative pediatric cardiac admissions were identified and included in the final analyses. Of these, a majority used at least one vasoactive agent at some point during the admissions with the median being three vasoactives. Each vasoactive was utilized with decreasing frequency throughout the study period except for vasopressin which increased in frequency of use. After adjusting for multiple confounding factors, only milrinone was associated with decreased inpatient mortality in any postoperative subset, while the rest of the vasoactive were associated with increased inpatient mortality in some of the postoperative subsets. Conclusion Vasoactive agents have decreased in frequency of use in postoperative pediatric cardiac admissions, except for vasopressin. Only milrinone was found to be associated with decreased inpatient mortality in any subset of these patients, while all other vasoactive agents were found to be associated with increased inpatient mortality at least in one of the subsets.

1 October 2021 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
RBRonald A. Bronicki
Ronald A. Bronicki
SFSaul Flores
Saul Flores
RLRohit S. Loomba
Rohit S. Loomba
PCPaul A. Checchia
Paul A. Checchia
UPUri Pollak
Uri Pollak
EGEric M. Graham
Eric M. Graham

4 December 2023 in Seminars in Ultrasound, CT and MRI
Verified
Journal Article
Closed access
SFSaul Flores
Saul Flores
ESErik Su
Erik Su
JMJustin M. Moher
Justin M. Moher
AAAdam C. Adler
Adam C. Adler
ARAlan F. Riley
Alan F. Riley

14 April 2023 in Hepatology Communications
Verified
Journal Article
Open access
MVManpreet K. Virk
Manpreet K. Virk
MMMuhammad Umair M. Mian
Muhammad Umair M. Mian
DBDalia A. Bashir
Dalia A. Bashir
JWJohn K. Wilkes
John K. Wilkes
TSTobias Schlingman
Tobias Schlingman
MDMoreshwar S. Desai
Moreshwar S. Desai
Background: In children with biliary atresia (BA), pathologic structural changes within the heart, which define cirrhotic cardiomyopathy, are associated with adverse perioperative outcomes. Despite their clinical relevance, little is known about the pathogenesis and triggers of pathologic remodeling. Bile acid excess causes cardiomyopathy in experimental cirrhosis, but its role in BA is poorly understood. Methods: Echocardiographic parameters of left ventricular (LV) geometry [LV mass (LVM), LVM indexed to height, left atrial volume indexed to BSA (LAVI), and LV internal diameter (LVID)] were correlated with circulating serum bile acid concentrations in 40 children (52% female) with BA listed for transplantation. A receiver-operating characteristic curve was generated to determine optimal threshold values of bile acids to detect pathologic changes in LV geometry using Youden index. Paraffin-embedded human heart tissue was separately analyzed by immunohistochemistry for the presence of bile acid-sensing Takeda G-protein-coupled membrane receptor type 5. Results: In the cohort, 52% (21/40) of children had abnormal LV geometry; the optimal bile acid concentration to detect this abnormality with 70% sensitivity and 64% specificity was 152 µmol/L (C-statistics=0.68). Children with bile acid concentrations >152 µmol/L had ∼8-fold increased odds of detecting abnormalities in LVM, LVM index, left atrial volume index, and LV internal diameter. Serum bile acids positively correlated with LVM, LVM index, and LV internal diameter. Separately, Takeda G-protein-coupled membrane receptor type 5 protein was detected in myocardial vasculature and cardiomyocytes on immunohistochemistry. Conclusion: This association highlights the unique role of bile acids as one of the targetable potential triggers for myocardial structural changes in BA.